Breakthrough T1D is inviting applications for its Innovative Research Grant, a funding opportunity designed to support bold, high-risk/high-reward projects in type 1 diabetes (T1D). The programme seeks early-stage research with the potential to transform how T1D is prevented, treated, or cured — particularly work not yet developed enough to qualify for larger, traditional grants from institutions such as the NIH.
Funding and Benefits
-
Grant amount: Up to $200,000 total costs for a one-year period.
-
Funding covers both direct and indirect costs.
-
Designed to help researchers generate preliminary data that can support future applications for major, long-term funding.
Eligibility
Applicants must:
-
Hold an M.D., Ph.D., D.V.M., or equivalent advanced degree.
-
Have a faculty position or comparable role at a recognized research institution (e.g., university, college, hospital, or laboratory).
-
Be affiliated with either a nonprofit or for-profit organisation.
-
Be based in the United States or internationally.
Application Guidelines
-
Proposals must focus on research directly relevant to T1D.
-
Applications should demonstrate clear potential for transformative impact, with strong plans for how preliminary findings could lead to significant breakthroughs.
-
Submissions must be completed using the RMS360 templates, available on the Breakthrough T1D website.
Deadline
-
Application deadline: October 30, 2025
-
Full applications, including research plans, must be submitted via RMS360.
For more information and to access the application templates, visit the Breakthrough T1D website.
Explore more global opportunities on our Opportunities page.
Summary not available at this time.
